期刊文献+

白三烯受体拮抗剂在支气管哮喘治疗中的合理应用

原文传递
导出
摘要 白三烯作为支气管哮喘(简称哮喘)气道炎症中的重要炎性介质,在哮喘的发病机制中发挥重要作用。本文结合2006年修订的《全球哮喘创议》(Global Initiative for Asthma,GINA)来分析白三烯受体拮抗剂在哮喘治疗中的地位和合理应用。
作者 辛晓峰
出处 《中华哮喘杂志(电子版)》 CAS 2008年第3期217-219,共3页 Chinese Journal of Asthma(Electronic Version)
  • 相关文献

参考文献7

  • 1辛晓峰,施毅.阿司匹林性哮喘的治疗[J].中华内科杂志,2003,42(4):276-278. 被引量:7
  • 2Steinshamn S,Sandsund M,Sue-Chu M,et al.Effects of montelukast and sal meterol on physical performance and exercise economy in adult asthmatics with exercise-induced bronchoconstriction. Chest . 2004 被引量:1
  • 3Milanese M,Passalacqua G,Pasquali M,et al.Role of leukotriene receptor antagonists in the management of mild-to-moderate asthma. Monaldi Archives for Chest Diseases Cardiac Series . 2001 被引量:1
  • 4Price DB,Hernandez D,Magyar P,et al.Randomised controlled trial of montelukast plus inhaled budesonide versus double dose inhaled budesonide in adult patients with asthma. Thorax . 2003 被引量:1
  • 5Bjermer L,Bisgaard H,Bousquet J,et al.Montelukast and fluticasone compared with salmeterol and fluticasone in protecting against asthma exacerbation in adults: one year, double blind, randomised, comparative trial. British Medical Journal . 2003 被引量:1
  • 6Philip G,,Nayak AS,Berger WE,et al.The effect of montelukast on rhinitis symptoms in patients with asthma and seasonal allergic rhinitis. Current Medical Research and Opinion . 2004 被引量:1
  • 7Pefers SP.Leukotriene receptor antagonist in asthma therapy. Allergy and Clinical Immunology International . 2003 被引量:1

二级参考文献15

  • 1Marquette CH, Saulnier F, Leroy O, et al. Long-term prognosis of near-fatal asthma. A 6-year fonow-up study of 145 asthmatic patients who underwent mechanical ventilation for a near-fatal attack of asthma. Am Rev Respir Dis, 1992,146:76-81. 被引量:1
  • 2Szczeklik A, Gryglewski R J, Czemiawska-Mysik G. Clinical patterns of hypersensitivity to nonsteroidal anti-inflammatory drugs and their pathogenesis. J Allergy Clin Immunol, 1977,60:276-284. 被引量:1
  • 3Bianco SR, Petrini G. Aspirin induced tolerance in aspirin-asthma detected by a new challenge test. IRCS J Med Sei, 1977,5:129-136. 被引量:1
  • 4Jawien J. A new insight into aspirin-induced asthma. Eur J Clin Invest,2002,32 : 134-138. 被引量:1
  • 5Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature New Biol, 1971,231:232-235. 被引量:1
  • 6Feldweg AM, Horan RF. Aspirin treatment of patients with aspirin intolerance, asthma, and nasal polyps. Allergy Asthma Proc,2001,22:377-382. 被引量:1
  • 7Juergens UR, Christiansen SC, Stevenson DD, et al. Inhibition of monocyte leukotriene B4 production after aspirin desensitization. J Allergy Clin Immunol, 1995,96 : 148-156. 被引量:1
  • 8Stevenson DD, Hankammer MA, Mathison DA, et al. Aspirin desensitization treatment of aspirin-sensitive patients with rhinosinusitis-asthma: long-term outcomes. J Allergy Clin Immunol,1996,98:751-758. 被引量:1
  • 9Dahlen B. Treatment of aspirin-intolerant asthma with antileukotrienes. Am J Respir Crit Care Med,2000, 161 (2 Pt 2):S137-S141. 被引量:1
  • 10Dahlen SE, Nizankowska E, Dahlen B, et al. The Swedish-Polish treatment study with the 5-1ipoxygenase inhibitor zileuton in aspirinintolerant asthmatics. Am J Respir Crit Care Med, 1995,151 :A376. 被引量:1

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部